IRVINE, Calif., Oct. 18, 2017 -- LoanScorecard™, a leading provider of loan pricing, automated underwriting and compliance solutions, announced today that Gerald Casey has joined the company as Managing Director, Capital Markets.
|
|||||
In this position, Casey will be responsible for identifying and pursuing LoanScorecard opportunities with originators, aggregators and issuers of non-agency assets, as well as developing and executing strategies to maximize revenues of non-agency capital market participants and investors. He will report to Ben Wu, Executive Director of LoanScorecard.
Casey brings more than 30 years of experience in the financial services industry as a fixed income, residential whole loan trading and technology professional to LoanScorecard with over $60 billion UPB of non-agency whole loans acquired and managed to-date. Most recently, he held the position of Managing Director with Hudson Advisors/Lone Star Funds. In this position, he was responsible for residential non-performing whole loan acquisitions and he acquired, underwrote and directed the default servicing at Caliber Home Loans, a wholly-owned operating company of Lone Star Funds, on over $29 billion UPB for Lone Star Funds’ investors.
Prior to Hudson Advisors/Lone Star Funds, Casey was a Portfolio Manager at Westport Capital Partners, an investment management company focused exclusively on opportunistic and distressed real estate investments. His career has also included senior trading, asset management and technology positions as a Principal at The Winter Group, a vertically integrated real estate investment management company, and as Director of Fixed Income Trading and Chief Technology Officer at Beacon Hill Asset Management, a hedge fund specializing in investing and trading mortgage-backed securities. Casey began his career in financial services providing technology solutions to Lipper Analytical Services, now Thomson Reuters Lipper, and Barron Funds.
“LoanScorecard is committed to supporting capital and secondary market players as they expand their non-agency and portfolio offerings,” said Wu. “Adding a leader with Gerald’s experience will allow us to better serve our clients by providing strategic solutions that make their businesses more efficient and effective.”
Casey received his MBA at Pace University and his Bachelor of Science in Finance at the University of Maryland.
About LoanScorecard
LoanScorecard™ is a leading provider of automated underwriting and loan pricing solutions designed to meet today's regulatory challenges and capitalize on market opportunities. The company’s Portfolio Underwriter™ can be tailored to capture a lender’s specific credit policy and render underwriting findings that demonstrate a consistent loan manufacturing process to auditors and investors. Portfolio Producer™ electronically distributes wholesale and investor products to third-party originators (TPOs), providing them with a real-time, interactive tool to determine borrower fit and risk-adjusted pricing for non-agency programs, and enabling them to submit qualified loans with confidence. Additionally, as the industry's first QM engine, LoanScorecard helps institutions address CFPB regulations through its QM Findings™, the industry's first qualified mortgage (QM) engine which has rendered more than 5 million QM findings reports to-date. For more information, visit loanscorecard.com or call 800-617-0892.
Contact:
Campbell Lewis Communications
Jessica Ruiz-Krout
212.995.8058
[email protected]


Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



